Table 1.
Characteristics of the study participants.
| Characterization of the participants | |||
|---|---|---|---|
| N | Percentage | ||
| Sex | Male | 104 | 61.2 |
| Woman | 66 | 38.2 | |
| Age | 7 years old | 47 | 27.6 |
| 8 years old | 61 | 35.9 | |
| 9 years old | 62 | 36.5 | |
| Diagnosis | ASD | 57 | 33.5 |
| ASD + Epilepsy | 53 | 31.2 | |
| Epilepsy | 60 | 35.3 | |
| Years of treatment | 2 years | 34 | 20.0 |
| 3 years | 73 | 42.9 | |
| 4 years | 63 | 37.1 | |
| Grade of incapacity | Less than 33% | 52 | 29.1 |
| Between 33 and 66% | 74 | 40 | |
| More than 66% | 44 | 30.9 | |
| Educational supports at school | Hearing and Language Teacher | 41 | 30.6 |
| Teacher of Hearing and Language and Therapeutic Pedagogy | 87 | 51.2 | |
| Hearing and Language Teacher, Therapeutic Pedagogy and Educator | 42 | 24.7 | |
| Gestation weeks | 30–35 | 52 | 30.6 |
| 35–40 | 87 | 51.2 | |
| More than 40 | 31 | 18.2 | |
| Apgar | With risk | 77 | 45.3 |
| Intermediate | 63 | 37.1 | |
| Normal | 30 | 17.6 | |
| Intellectual disability | No presence | 123 | 72.4 |
| Mind | 47 | 27.6 | |
| Pharmacological therapy | No presence | 52 | 30.6 |
| Valproate | 41 | 24.1 | |
| Risperidone | 19 | 11.2 | |
| Clonazepam | 58 | 34.1 | |